DiscoveRx Corporation Breaks the Barriers of Conventional Cell-Based Screening with Launch of a Powerful New InCELL Hunter™ Platform
6/5/2012 10:49:55 AM
FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx, a leader in innovative cell-based assays for GPCRs, Kinases, NHRs and Proteases, today unveiled a break-through technology called InCELL Hunter™. This platform marks a significant step forward as compared to other cell-based assay platforms currently available for Kinases, Epigenetics and other enzyme targets. This novel technology allows researchers to evaluate compound binding to a target of interest directly in a cellular environment.
comments powered by